MEDICAL MYCOLOGY
Scope & Guideline
Connecting Research and Practice in Infectious Diseases
Introduction
Aims and Scopes
- Fungal Pathogenesis and Host Interaction:
Research on the mechanisms by which fungi cause disease, including their interactions with the host immune system, cellular responses, and virulence factors. - Epidemiology of Fungal Infections:
Investigating the distribution, determinants, and dynamics of fungal infections globally, with a focus on emerging and re-emerging pathogens. - Antifungal Resistance and Drug Development:
Studies addressing the mechanisms of antifungal resistance, susceptibility testing, and the development of new antifungal agents and therapeutic strategies. - Clinical Management of Fungal Diseases:
Research on clinical outcomes, treatment options, and management strategies for various fungal infections, including case studies and large cohort analyses. - Diagnostic Innovations:
Advancements in diagnostic techniques for fungal infections, including molecular methods, serological tests, and the development of rapid diagnostic tools. - Mycology in Animal Health:
Exploration of fungal diseases affecting animals, their zoonotic potential, and the implications for public health. - Environmental Mycology:
Research on the role of environmental fungi in human health, including their implications in allergies, asthma, and other respiratory diseases.
Trending and Emerging
- COVID-19-Associated Fungal Infections:
Research on the rise of fungal infections related to COVID-19, particularly mucormycosis and candidemia, has surged, highlighting the intersection of viral and fungal diseases. - Molecular Epidemiology and Genotyping:
There is a growing trend towards using molecular techniques for the epidemiological study of fungal pathogens, focusing on genetic diversity, strain typing, and tracking outbreaks. - Fungal Biofilms and Resistance Mechanisms:
An increasing number of studies are addressing the formation of biofilms by fungal pathogens and their implications for treatment resistance, particularly in candidiasis. - Novel Antifungal Compounds and Therapies:
Research into new antifungal agents, including novel compounds and combination therapies, is on the rise, reflecting the urgent need to combat resistant fungal strains. - Fungal Immunology and Vaccine Development:
Emerging interest in understanding host immune responses to fungal infections and the potential for vaccine development is becoming a prominent area of research. - Zoonotic Fungal Infections:
Research on zoonotic fungi and their implications for human health is gaining attention, particularly in the context of environmental changes and animal health.
Declining or Waning
- Traditional Antifungal Therapies:
There has been a noticeable shift towards exploring new antifungal compounds and strategies, leading to less emphasis on established therapies, such as polyenes and older azoles. - Basic Mycological Taxonomy:
Research focused solely on the taxonomy of fungi without direct clinical implications has decreased, as the journal increasingly prioritizes studies with direct relevance to human health. - Invasive Fungal Infections in Non-Immunocompromised Hosts:
The focus on invasive fungal infections in generally healthy individuals is waning, reflecting a growing emphasis on immunocompromised populations and patients with comorbidities. - Fungal Ecology without Clinical Context:
Studies exploring fungal ecology that do not connect findings to clinical outcomes or implications for health are becoming less common in the journal.
Similar Journals
SYDOWIA
Navigating the Frontiers of Ecological and Botanical ResearchSYDOWIA is a prestigious academic journal based in Austria, published by Verlag Ferdinand Berger Sohne Gesellschaft mbH, that has been a cornerstone of scientific publishing since its establishment in 1996. With an ISSN of 0082-0598, SYDOWIA focuses on critical research in the fields of Ecology, Evolution, Behavior and Systematics as well as Plant Science, earning a notable classification in Category Quartiles with Q3 in Ecology-related disciplines and Q2 in Plant Science for 2023. The journal’s strategic insights into agricultural and biological sciences have secured a place within the Scopus rankings, where it holds the position of #191 out of 516 in Plant Science and #278 out of 721 in Ecology categories—reflecting its growing influence with a percentile standing of 63rd and 61st, respectively. Although SYDOWIA is not an Open Access journal, it continues to thrive in delivering scholarly articles that promote advancement and innovation in ecological and botanical research. Researchers, professionals, and students alike can rely on SYDOWIA as a vital resource for disseminating knowledge and fostering exploration in these essential scientific domains.
FUNGAL DIVERSITY
Innovating Ecological Understanding Through Fungal ResearchFungal Diversity is a premier academic journal dedicated to advancing the science of mycology, encompassing ecological, evolutionary, and biological research involving fungi. Published by Springer, this journal has established a significant presence in the academic community since its inception in 1998, and it continues to thrive with a convergence period extending to 2024. Holding a prestigious Q1 ranking in several categories — including Ecology, Ecology, Evolution, Behavior and Systematics, and Plant Science — Fungal Diversity showcases cutting-edge research that influences ecological management, conservation, and biodiversity studies. With its notable positions in Scopus rankings, including being ranked #1 in Environmental Science - Ecology, the journal serves as an essential resource for researchers, professionals, and students interested in the complex interplay between fungi and their environments. Although it does not currently offer open access, interested readers can benefit from the journal's rich repository of peer-reviewed articles, making Fungal Diversity a vital component of the scientific literature landscape.
Fungal Ecology
Exploring the Intricacies of Fungal InteractionsFungal Ecology, published by Elsevier Science Ltd, is a leading international journal dedicated to the exploration and advancement of our understanding of fungal biology and its ecological significance. With an impressive impact factor and recognized in the second quartile (Q2) across various categories such as Ecological Modeling, Ecology, Ecology, Evolution, Behavior and Systematics, and Plant Science, this journal offers a critical platform for researchers and professionals to disseminate and discuss innovations in fungal ecology. Since its inception in 2008, the journal has built a solid reputation, particularly highlighted by its impressive Scopus rankings, including a top percentile status in ecological fields. Researchers are encouraged to submit their findings that contribute to the understanding of the ecological roles of fungi, their interactions within ecosystems, and their applications in environmental science. Although the journal does not offer open access, it remains a vital resource for academics and practitioners aiming to stay ahead in the rapidly evolving fields of fungal research and ecology. Located in the vibrant heart of the Netherlands, the journal continues to foster scholarly engagement and collaboration among scientists globally.
Fungal Biology
Bridging Ecology and Health Through Fungal StudiesFungal Biology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of mycology and its interdisciplinary applications. With an ISSN of 1878-6146 and E-ISSN 1878-6162, this journal serves as a vital platform for researchers and professionals interested in the ecological, evolutionary, and genetic aspects of fungi, as well as their implications in infectious diseases and plant sciences. As of 2023, it proudly holds a Q2 ranking in Ecology, Evolution, Behavior and Systematics and Plant Science, and a Q3 ranking in Genetics and Infectious Diseases, highlighting its significant contribution to these domains. The journal boasts an impressive Scopus rank, including a percentile of 83rd in Ecological studies, ensuring that published research reaches a wide audience and impacts ongoing discourse in the field. With open access options, Fungal Biology encourages the dissemination of high-quality research, aimed to foster collaboration and innovation among scholars and practitioners. With its convergence of knowledge from 2010 to 2024, this journal is instrumental for those advancing the understanding of fungal biology and its myriad applications in environmental and health sciences.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Driving innovation in the study of microbes and their immune interactions.Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.
JOURNAL DE MYCOLOGIE MEDICALE
Empowering Knowledge in Fungal PathologyJOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.
MYCOLOGICAL PROGRESS
Leading the charge in mycological discoveries and applications.MYCOLOGICAL PROGRESS, published by SPRINGER HEIDELBERG, is an esteemed journal dedicated to advancing the field of mycology and associated biological disciplines. With an ISSN of 1617-416X and an E-ISSN of 1861-8952, this journal has established itself as a leading source of high-quality research, evidenced by its impressive rankings in the Q1 quartile across various categories such as Agricultural and Biological Sciences, Ecology, and Plant Science. As of 2023, MYCOLOGICAL PROGRESS ranks 37 out of 193 in Agricultural and Biological Sciences (miscellaneous) and 183 out of 721 in Ecology, demonstrating its significant impact in the ecosystem of scientific literature. This journal not only aims to disseminate innovative research findings but also strives to foster interdisciplinary collaboration among scientists, ecologists, and agriculturists around the globe. While retaining a traditional model of publication, MYCOLOGICAL PROGRESS remains crucial for those seeking to deepen their understanding of fungal biology and its broader environmental implications.
STUDIES IN MYCOLOGY
Unraveling the Mysteries of Fungi and Their EcosystemsSTUDIES IN MYCOLOGY is a premier journal dedicated to advancing research in the field of mycology, published by the renowned WESTERDIJK FUNGAL BIODIVERSITY INSTITUTE. With an impact factor that places it in the top quartile (Q1) of both Agricultural and Biological Sciences and Plant Science categories, it holds a prestigious position in the scientific community, ranking #1 out of 193 in its field as per Scopus metrics. Since its transition to Open Access in 2008, it has made significant strides in disseminating high-quality research widely, fostering a greater understanding of fungal biodiversity and its ecological impact. Covering a broad spectrum of topics related to mycology, the journal aims to provide researchers, professionals, and students with a platform for sharing innovative findings, stimulating academic discourse, and promoting collaborative efforts within this vital area of study. Hailing from the Netherlands, STUDIES IN MYCOLOGY serves as an invaluable resource for exploring the complexities of fungi, their interactions with various ecosystems, and their practical applications in agriculture and beyond.
MYCOLOGIA
Connecting researchers to the forefront of mycological science.MYCOLOGIA, published by Taylor & Francis Inc, is a prestigious journal that has been at the forefront of fungal research since its inception, with converging years of publication from 1945 to 2024. This interdisciplinary journal, identified by ISSN 0027-5514 and E-ISSN 1557-2536, stands out in various scientific categories, achieving Q1 rankings in Ecology, Evolution, Behavior and Systematics, as well as Plant Science, alongside strong performances in Cell Biology and Molecular Biology categories. With an impact factor that reflects its significance in the field, MYCOLOGIA appeals to a diverse audience, including researchers, professionals, and students dedicated to advancing the understanding of fungal biology and its ecological implications. Notably, while it does not currently operate under an Open Access model, the journal remains a vital resource for those pursuing groundbreaking discoveries in mycology and related disciplines.
Journal of Pediatric Infection
Transforming pediatric care with cutting-edge insights.Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.